2022. EFFECTIVENESS OF EMPIRIC ANTITUBERCULAR THERAPY TO TREAT CERVICAL GRANULOMATOUS LYMPHADENOPATHY AMONG PATIENTS NOT CONFIRMED TO HAVE MYCOBACTERIUM TUBERCULOSIS INFECTION: EMPIRICAL ANTITUBERCULAR THERAPY FOR LYMPHADENOPATHY. The Southeast Asian Journal of Tropical Medicine and Public Health. 53, 1 (Feb. 2022), 50–57.